Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F03W6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,922
Award facts
- Contract value 100% obligated
- $16,921.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,921.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 mL) pharmaceutical supply on January 30, 2026, with completion targeted for February 2, 2026. The award was made on a non-set-aside, competitive basis, and the place of performance is located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., functions as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The company's extensive federal contracting portfolio demonstrates its capability to fulfill open competition requirements across diverse therapeutic domains, including diabetes medications, specialty pharmaceuticals, vaccines, and medical devices. The DLA Troop Support Medical contract represents a strategic procurement vehicle designed to ensure reliable supply chain access to essential pharmaceutical commodities for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26F03W6?
SPE2DR26F03W6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F03W6 worth?
The government has obligated $16,922 on SPE2DR26F03W6.
Is contract SPE2DR26F03W6 an order under another contract?
Yes. SPE2DR26F03W6 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F03W6 competed?
The extent of competition for SPE2DR26F03W6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award